Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study
- PMID: 38965089
- PMCID: PMC11224114
- DOI: 10.1007/s40520-024-02804-9
Pancreaticoduodenectomy in patients < 75 years versus ≥ 75 years old: a comparative study
Abstract
Objective: This study aimed to compare the postoperative outcomes of < 75-year-old patients and ≥ 75-year-old patients who underwent pancreaticoduodenectomy (PD) for pancreatic head and periampullary region tumors.
Methods: Patients who underwent PD in our hospital between February 2019 and December 2023 were evaluated. Demographics, Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scores, American Society of Anesthesiologists (ASA) scores, comorbidities, hospital stays, complications, and clinicopathological features were analyzed. Patients were divided into < 75 years (Group A) and ≥ 75 years (Group B) groups and compared.
Results: The median age of the entire cohort (n = 155) was 66 years (IQR = 16). There was a significant difference between Group A (n = 128) and Group B (n = 27) regarding the ECOG-PS and ASA scores. There was no significant difference between the groups regarding postoperative complications. The 30-day mortality rate was greater in Group B (p = 0.017). Group B had a cumulative median survival of 10 months, whereas Group A had a median survival of 28 months, with a statistically significant difference (p < 0.001). When age groups were stratified according to ECOG-PS, for ECOG-PS 2-3 Group A, survival was 15 months; for ECOG-PS 2-3 Group B, survival was eight months, and the difference was not statistically significant (p = 0.628).
Conclusions: With the increasing aging population, patient selection for PD should not be based solely on age. This study demonstrated that PD is safe for patients older than 75 years. In older patients, performance status and the optimization of comorbidities should be considered when deciding on a candidate's suitability for surgery.
Keywords: Elderly; Geriatric surgery; Pancreatectomy; Pancreatic adenocarcinoma; Performance status; Survival.
© 2024. The Author(s).
Conflict of interest statement
The authors have no relevant financial or nonfinancial interests to disclose.
Figures


Similar articles
-
Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head is justified in elderly patients: A Retrospective Cohort Study.Int J Surg. 2016 Apr;28:118-25. doi: 10.1016/j.ijsu.2016.02.064. Epub 2016 Feb 21. Int J Surg. 2016. PMID: 26906329
-
The safety of a pancreaticoduodenectomy in patients older than 80 years: risk vs. benefits.HPB (Oxford). 2012 Sep;14(9):583-8. doi: 10.1111/j.1477-2574.2012.00484.x. Epub 2012 May 29. HPB (Oxford). 2012. PMID: 22882194 Free PMC article.
-
A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age.J Hepatobiliary Pancreat Surg. 2009;16(5):675-80. doi: 10.1007/s00534-009-0106-6. Epub 2009 Apr 22. J Hepatobiliary Pancreat Surg. 2009. PMID: 19387530
-
Outcome of pancreaticoduodenectomy in octogenarians: Single institution's experience and review of the literature.J Visc Surg. 2015 Nov;152(5):279-84. doi: 10.1016/j.jviscsurg.2015.06.004. Epub 2015 Jun 24. J Visc Surg. 2015. PMID: 26117303 Review.
-
Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?Am J Surg. 2001 Aug;182(2):120-9. doi: 10.1016/s0002-9610(01)00686-9. Am J Surg. 2001. PMID: 11574081 Review.
References
-
- Uprak TK, Ergenc M. Older is worse? Elderly patients who underwent gastrectomy: a single-center study. Ann Ital Chir. 2023;94:268–273. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical